Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sarepta Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Oct 2016 Reuters Investment Profile 12 $20.00

Sarepta Therapeutics, Inc. (SRPT) - Financial and Strategic SWOT Analysis Review

Sarepta Therapeutics, Inc. (SRPT) - Financial and Strategic SWOT Analysis Review Summary Sarepta Therapeutics, Inc. (Sarepta)...

02 Nov 2016 GlobalData 79 $300.00

Trading Report for (SRPT). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for SRPT. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

02 Nov 2016 Stock Traders Daily 12 $20.00

Thomson Reuters Stock Report - Sarepta Therapeutics Inc (SRPT-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for SRPT

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

30 Oct 2016 ValuEngine, Inc. 11 $25.00

Our Economy without Stimulus; forward observations.

FOMC Stimulus Programs have exaggerated the naturalized economic growth rates in our Economy as those are defined by the Inve...

29 Oct 2016 Stock Traders Daily 102 $20.00

SAREPTA THERAPEUTICS INC (SRPT=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

29 Oct 2016 Pechala's Reports 2 $25.00

Value Graph: SAREPTA THERAPEU -- SRPT

28 Oct 2016 Ford Investor Services, Inc. 1 $12.00

Sarepta Therapeutics

22 Oct 2016 S&P Capital IQ Quantitative Report 12 $138.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of SAREPTA THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

21 Oct 2016 Jefferson Research 11 $20.00